Cite
HARVARD Citation
Berenguer, J. et al. (2018). All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings. Hepatology. 68 (1), pp. 32-47. [Online].